A Busy Spring in the Education Department
The Education Department is hard at work evaluating over 390 student applications and looking forward to hosting presentations and visiting professional fairs in the coming weeks.
Latest News
Posts that will appear within the SRF Blog
New Peer-Reviewed Paper from SENS Research Foundation: Iron Homeostasis as a Senolytic Target
Scientists at SENS Research Foundation led by Dr. Tesfahun (Tes) Dessale Admasu have just published their exciting new senolytic strategy to destroy a wider range of senescent cells than has up to now been possible.
Announcement: Amicable Settlement of Donor Dispute
SENS Research Foundation and Concerned Donors, LLC, Paul Bugge, and Dr. Gary Baskin are pleased to announce that the dispute regarding the use of donor funds has been amicably settled to their satisfaction.
The Zombie Problem Happening Inside You
Don’t miss our new super fun SRF and Life Noggin animation about zombie cells and the SENS damage repair approach!
This video describes our work on finding ways to slow down or even reverse the accumulation of senescent cells.
Announcing the new Chairman of the SRF Board of Directors
SRF is pleased to announce that Bill Liao has been appointed Chairman of the Board of Directors. He’s been serving as a Director and Board Secretary since the beginning of SRF. Bill Liao is a Chinese-Australian-Irish entrepreneur, investor, former diplomat, business mentor, author, passionate leader and speaker, with a distinguished record in business development and community activism.
A Message from the SRF Board of Directors
Invitation for Dr. De Grey and Richard Heart to join the Board of Directors
New Peer-Reviewed Paper from SENS Research Foundation Reports a Better Method to Study How Immune Cells Seek and Destroy Senescent Cells
We are proud to announce the recent publication by Sharma lab/ApoptoSENS team in the journal Aging describing an improved method for enriching primary NK cells from human peripheral blood and demonstrating the ability of those NK cells to eliminate senescent cells by recapitulating more physiological conditions and potential therapeutic interventions.
We are thrilled to announce the expansion of our Research Center
We are thrilled to announce the expansion of our Research Center to over 11,000 sq. feet with the addition of new lab and office space. This is more than doubling our current facility.
Michael Rae and Dr. Robert Rodgers discuss Parkinson’s and aging
SENS Research Foundation’s science writer Michael Rae was interviewed on the Parkinson’s Recovery radio program on “The coming rejuvenation biotechnology revolution for Parkinson’s disease.” In it, they discussed how the cellular and molecular damage of aging most closely involved in Parkinson’s can be removed, replaced, or repaired using rejuvenation biotechnologies, and research underway to make it happen. Read more and listen to the interview to learn how a “damage-repair” approach can prevent, arrest, and eventually consign Parkinson’s to history.
SENS Research Foundation & Underdog Pharmaceuticals jointly awarded $252,000 NIA research grant
The National Institute on Aging (NIA) division of the National Institutes of Health (NIH) has awarded a grant to advance research on Engineered Cyclodextrins targeting toxic oxidized cholesterol to eradicate atherosclerosis — the cause of most heart attacks and strokes.
Former SRF V.P. of Research and current Underdog Co-founder Matthew O’Connor, Ph.D. and current SRF V.P. of Research Alexandra Stolzing, Ph.D., are the Principal Investigators.
